UBS Group’s Serina Therapeutics SER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6 | Sell |
1
-746
| -100% | -$4.48K | ﹤0.01% | 8845 |
|
|
2025
Q1 | $4.24K | Sell |
747
-3,062
| -80% | -$17.4K | ﹤0.01% | 7816 |
|
|
2024
Q4 | $19.1K | Buy |
3,809
+3,808
| +380,800% | +$19.1K | ﹤0.01% | 6675 |
|
|
2024
Q3 | $7 | Sell |
1
-1,026
| -100% | -$7.18K | ﹤0.01% | 8158 |
|
|
2024
Q2 | $9.84K | Buy |
1,027
+1,022
| +20,440% | +$9.79K | ﹤0.01% | 6569 |
|
|
2024
Q1 | $67 | Sell |
5
-13
| -72% | -$174 | ﹤0.01% | 7718 |
|
|
2023
Q4 | $238 | Buy |
18
+11
| +157% | +$145 | ﹤0.01% | 7568 |
|
|
2023
Q3 | $160 | Sell |
7
-154
| -96% | -$3.52K | ﹤0.01% | 7619 |
|
|
2023
Q2 | $5.06K | Buy |
161
+160
| +16,000% | +$5.03K | ﹤0.01% | 6395 |
|
|
2023
Q1 | $23 | Sell |
1
-383
| -100% | -$8.81K | ﹤0.01% | 8307 |
|
|
2022
Q4 | $7.43K | Buy |
384
+383
| +38,300% | +$7.41K | ﹤0.01% | 7701 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 9777 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 9821 |
|
|
2022
Q1 | $0 | Sell |
1
-446
| -100% | – | ﹤0.01% | 9690 |
|
|
2021
Q4 | $17K | Buy |
447
+445
| +22,250% | +$16.9K | ﹤0.01% | 6968 |
|
|
2021
Q3 | $0 | Buy |
2
+1
| +100% | – | ﹤0.01% | 8846 |
|
|
2021
Q2 | $0 | Sell |
1
-56
| -98% | – | ﹤0.01% | 8642 |
|
|
2021
Q1 | $4K | Sell |
57
-136
| -70% | -$9.54K | ﹤0.01% | 7395 |
|
|
2020
Q4 | $10K | Sell |
193
-409
| -68% | -$21.2K | ﹤0.01% | 6482 |
|
|
2020
Q3 | $17K | Buy |
602
+391
| +185% | +$11K | ﹤0.01% | 5581 |
|
|
2020
Q2 | $7K | Sell |
211
-198
| -48% | -$6.57K | ﹤0.01% | 6380 |
|
|
2020
Q1 | $13K | Sell |
409
-505
| -55% | -$16.1K | ﹤0.01% | 5878 |
|
|
2019
Q4 | $59K | Buy |
914
+351
| +62% | +$22.7K | ﹤0.01% | 5217 |
|
|
2019
Q3 | $39K | Buy |
563
+311
| +123% | +$21.5K | ﹤0.01% | 5382 |
|
|
2019
Q2 | $33K | Buy |
252
+153
| +155% | +$20K | ﹤0.01% | 5399 |
|
|
2019
Q1 | $14K | Sell |
99
-20
| -17% | -$2.83K | ﹤0.01% | 5767 |
|
|
2018
Q4 | $12K | Buy |
+119
| New | +$12K | ﹤0.01% | 6227 |
|